Myths vs facts: CYP1A2 and menopause

CYP1A2 metabolizes caffeine and estrogens. A common myth is that menopausal women must avoid caffeine entirely because their metabolism slows. In fact, declining estrogen during menopause reduces CYP1A2 activity by about 30%, prolonging caffeine's effects and potentially worsening sleep disturbances or hot flashes. However, the impact is individual: carriers of the fast CYP1A2 variant (rs762551 AA) still clear caffeine relatively efficiently. A DNA test can provide insight but does not replace medical advice. The fact is: menopause alters caffeine metabolism, but a blanket ban is not evidence-based. Evidence is moderate – association studies exist, but no large clinical trials for personalized recommendations. Caveat: other factors like medications, smoking, and liver health also affect CYP1A2 activity.